Eyenovia, Inc. announced that Stephen Benjamin, an independent director on the Company's Board of Directors, is stepping down to assume the role of Head of the White House's Office of Public Engagement. Mr. Benjamin, an attorney, former three-term mayor of Columbia, South Carolina and 76th President of the U.S. Conference of Mayors, with an extensive record of achievement in government and the public sector, joined the Eyenovia Board in February 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.07 USD | +7.32% |
|
+22.71% | -48.56% |
Jul. 01 | NovaBay Pharmaceuticals, Eyenovia Begin Co-Promotion Deal Activities | MT |
Jul. 01 | NovaBay Pharmaceuticals, Inc. and Eyenovia, Inc. Commence Co-Promotion Activities | CI |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-48.56% | 73.85M | |
+62.66% | 854B | |
+40.42% | 636B | |
-4.37% | 361B | |
+17.16% | 324B | |
+9.87% | 301B | |
+15.66% | 247B | |
+4.21% | 230B | |
+17.90% | 228B | |
+14.86% | 177B |
- Stock Market
- Equities
- EYEN Stock
- News Eyenovia, Inc.
- Eyenovia Announces Independent Director Stephen Benjamin to Step Down to Assume Role of Head of White House’s Office of Public Engagement